Filing Flows

Filing Flows › Ultralife (ULBI) › Takeover & LBO

Is Ultralife (ULBI) a takeover target?

A leveraged buyout does not work for Ultralife on its latest figures: the figures a buyout model needs (revenue, EBITDA, the share count and the price) are not all on file. Historically 6.9% of companies with its figures were bought within a year (1.37× the average). Latest signal (2026-10-28): Agreed sale to Section 251 at $14.0 cash a share · pending.

Why a leveraged buyout does not fit

The buyout model needs Ultralife's revenue, EBITDA, share count and share price; not all of them are on file, so it gives no buyout price.

What a takeover could cost

Takeovers in its sector paid a median premium of 30% over the share price before the deal (the middle half 12% to 31%), according to the 14 merger proxies and tender-offer responses on EDGAR that state a premium.

The odds, from history

Historically 6.9% of companies with its figures were bought within a year (1.37× the average). Its figures put it in decile 9 of 10 (10 = the most likely to be bought). The odds come from a model of every merger proxy, tender-offer response and going-private statement filed on EDGAR since 2011, set against each company's size, margins, debt, cash flow and growth the year before.

Rumors and deal signals

Ultralife's latest quarter

Ultralife, Q3 2026: revenue $48.3M (+11% year over year), operating margin 6.6%, net earnings $2.4M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.

Questions

Is Ultralife being acquired?

The latest signal on file is from 2026-10-28: Agreed sale to Section 251 at $14.0 cash a share · pending. A headline is not a deal; Filing Flows lists the news, 8-K filings and 13D filings about a sale.

Could private equity buy Ultralife?

A leveraged buyout does not work for Ultralife on its latest figures: the figures a buyout model needs (revenue, EBITDA, the share count and the price) are not all on file. The model gives no buyout price until they are.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.